Literature DB >> 33658625

Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion.

Yingyi Ma1, Haiye Wang2.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common malignant epithelial neoplasm of the head and neck, with poorer prognosis. There is lack of specific targets for diagnosis and treatment of OSCC at present. Annexin A2 (ANXA2) is involved in cell angiogenesis, invasion, proliferation and metastasis. In this study, the significance and effect of ANXA2 on OSCC and OSCC cells were explored from the clinical and basic study. First, ANXA2 expression in OSCC tissues and adjacent non-cancer tissues of 124 patients were detected, and the correlation between ANXA2 expression and clinical parameters were analyzed. The results found that ANXA2 was highly expressed in OSCC tissues, and was associated with the TNM stage, tumor differentiation, lymph node metastasis and poor survival of OSCC patients. The expression of ANXA2 in OSCC cells were higher than the normal oral cells. And knockdown of ANXA2 by transfecting ANXA2-siRNA could suppress the proliferation, migration, and invasion abilities of OSCC cells. Overall, ANXA2 expression is correlated with poor survival of OSCC patients, and silencing of ANXA2 suppress the proliferation, migration and invasion of OSCC cells.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33658625      PMCID: PMC7930260          DOI: 10.1038/s41598-021-84675-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  Clinicopathological prognostic factors of oral squamous cell carcinoma: An experience of a tertiary care hospital.

Authors:  Sayed Akbar Abbas; Javeria Saeed; Muhammad Usman Tariq; Ahmed Raheem Baksh; Salman Hashmi
Journal:  J Pak Med Assoc       Date:  2018-07       Impact factor: 0.781

2.  Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.

Authors:  Wei Zhang; Chunhai Gao; Shaohua Zhang; Guiqing Fang
Journal:  J Oral Maxillofac Surg       Date:  2016-11-04       Impact factor: 1.895

Review 3.  Hypoxia: Signaling the Metastatic Cascade.

Authors:  Erinn B Rankin; Jin-Min Nam; Amato J Giaccia
Journal:  Trends Cancer       Date:  2016-06-02

4.  Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma.

Authors:  Juan P Rodrigo; Paloma Lequerica-Fernández; Pablo Rosado; Eva Allonca; Juana M García-Pedrero; Juan C de Vicente
Journal:  Head Neck       Date:  2011-04-15       Impact factor: 3.147

Review 5.  Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis.

Authors:  Xinyu Liu; Ding Ma; Xiaoqian Jing; Bingrui Wang; Weiping Yang; Weihua Qiu
Journal:  Med Oncol       Date:  2014-12-05       Impact factor: 3.064

6.  Increased expression of Annexin A2 in oral squamous cell carcinoma.

Authors:  Lai-ping Zhong; Kui-jie Wei; Xiao Yang; Lei Zhang; Xiao-jian Zhou; Hong-ya Pan; Jiang Li; Wan-tao Chen; Zhi-yuan Zhang
Journal:  Arch Oral Biol       Date:  2008-09-25       Impact factor: 2.633

7.  Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.

Authors:  Terrick Andey; Srujan Marepally; Apurva Patel; Tanise Jackson; Shubhashish Sarkar; Malaney O'Connell; Rakesh C Reddy; Srikumar Chellappan; Pomila Singh; Mandip Singh
Journal:  J Control Release       Date:  2014-04-12       Impact factor: 9.776

8.  Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.

Authors:  Hai-Jian Zhang; Deng-Fu Yao; Min Yao; Hua Huang; Li Wang; Mei-Juan Yan; Xiao-Di Yan; Xing Gu; Wei Wu; Shao-Lin Lu
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

9.  Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.

Authors:  Adrian G Murphy; Kelly Foley; Agnieszka A Rucki; Tao Xia; Elizabeth M Jaffee; Chiung-Yu Huang; Lei Zheng
Journal:  Oncotarget       Date:  2017-11-15

10.  ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.

Authors:  Sai Ma; Chen-Chen Lu; Li-Yan Yang; Juan-Juan Wang; Bo-Shi Wang; Hong-Qing Cai; Jia-Jie Hao; Xin Xu; Yan Cai; Yu Zhang; Ming-Rong Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-08-06
View more
  2 in total

1.  Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.

Authors:  Khalid Akkour; Ibrahim O Alanazi; Assim A Alfadda; Hani Alhalal; Afshan Masood; Mohthash Musambil; Anas M Abdel Rahman; Moudi A Alwehaibi; Maria Arafah; Ali Bassi; Hicham Benabdelkamel
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

Review 2.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.